Secondary Osteosarcoma
1 clinical trials · Condition
◉ Watch Secondary Osteosarcoma
| Record | Firm | Date |
|---|---|---|
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma (NCT05691478) | National Cancer Institute (NCI) | 2023-03-03 |
Track Secondary Osteosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.